{"title":"基于下一代测序的艾灸干预动脉粥样硬化机制研究","authors":"Jia Yang, Hanxi Dai, Shiwan Hu, Kun Cai","doi":"10.1166/jbn.2023.3673","DOIUrl":null,"url":null,"abstract":"This study aimed to investigate the underlying mechanism through which moxibustion intervention therapy improves platelet activation in rats with atherosclerosis using Next Generation Sequencing (NGS). Atherosclerosis models were established in 15 Apolipoprotein E knockout mice (ApoE-/- mice) aged 8 weeks, while non-transgenic mice (C57BL/6) were used as the control group. The mice were divided into four groups: moxibustion group, clopidogrel group, model group, and blank control group. Following 12 weeks of intervention, platelet-rich plasma was prepared from venous blood collected from the mice’s eyeballs. RNA extraction and analysis were performed to assess gene expression patterns. In the moxibustion group, the expression of PPBP was downregulated, while PTPN7 expression was upregulated, indicating involvement in the MAPK classical pathway. The moxibustion group exhibited significantly higher PTPN7 mRNA expression compared to both the clopidogrel and model groups, while Robo4 mRNA expression was significantly reduced in both the moxibustion and clopidogrel groups. The PTPN7 gene locus, acting through the MAPK pathway, may serve as a potential target for enhancing atherosclerosis management by modulating platelet activation.","PeriodicalId":15260,"journal":{"name":"Journal of biomedical nanotechnology","volume":"31 1","pages":"0"},"PeriodicalIF":2.9000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research on the Mechanism of Moxibustion Intervention in Atherosclerosis Based on Next Generation Sequencing\",\"authors\":\"Jia Yang, Hanxi Dai, Shiwan Hu, Kun Cai\",\"doi\":\"10.1166/jbn.2023.3673\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study aimed to investigate the underlying mechanism through which moxibustion intervention therapy improves platelet activation in rats with atherosclerosis using Next Generation Sequencing (NGS). Atherosclerosis models were established in 15 Apolipoprotein E knockout mice (ApoE-/- mice) aged 8 weeks, while non-transgenic mice (C57BL/6) were used as the control group. The mice were divided into four groups: moxibustion group, clopidogrel group, model group, and blank control group. Following 12 weeks of intervention, platelet-rich plasma was prepared from venous blood collected from the mice’s eyeballs. RNA extraction and analysis were performed to assess gene expression patterns. In the moxibustion group, the expression of PPBP was downregulated, while PTPN7 expression was upregulated, indicating involvement in the MAPK classical pathway. The moxibustion group exhibited significantly higher PTPN7 mRNA expression compared to both the clopidogrel and model groups, while Robo4 mRNA expression was significantly reduced in both the moxibustion and clopidogrel groups. The PTPN7 gene locus, acting through the MAPK pathway, may serve as a potential target for enhancing atherosclerosis management by modulating platelet activation.\",\"PeriodicalId\":15260,\"journal\":{\"name\":\"Journal of biomedical nanotechnology\",\"volume\":\"31 1\",\"pages\":\"0\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biomedical nanotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1166/jbn.2023.3673\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1166/jbn.2023.3673","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
Research on the Mechanism of Moxibustion Intervention in Atherosclerosis Based on Next Generation Sequencing
This study aimed to investigate the underlying mechanism through which moxibustion intervention therapy improves platelet activation in rats with atherosclerosis using Next Generation Sequencing (NGS). Atherosclerosis models were established in 15 Apolipoprotein E knockout mice (ApoE-/- mice) aged 8 weeks, while non-transgenic mice (C57BL/6) were used as the control group. The mice were divided into four groups: moxibustion group, clopidogrel group, model group, and blank control group. Following 12 weeks of intervention, platelet-rich plasma was prepared from venous blood collected from the mice’s eyeballs. RNA extraction and analysis were performed to assess gene expression patterns. In the moxibustion group, the expression of PPBP was downregulated, while PTPN7 expression was upregulated, indicating involvement in the MAPK classical pathway. The moxibustion group exhibited significantly higher PTPN7 mRNA expression compared to both the clopidogrel and model groups, while Robo4 mRNA expression was significantly reduced in both the moxibustion and clopidogrel groups. The PTPN7 gene locus, acting through the MAPK pathway, may serve as a potential target for enhancing atherosclerosis management by modulating platelet activation.